title: Development of EBV-positive T-cell lymphoma following infection of peripheral blood T cells with EBV.
abstract: Chronic active Epstein-Barr virus (EBV) infection is manifested clinically by the persistence of infectious mononucleosis-like symptoms or its complications for a prolonged period ranging from one to several years. This syndrome may include severe disease manifestations and can be fatal. The role of EBV in the pathogenesis of chronic active EBV infection has been unclear. We investigated two Japanese patients with severe chronic active EBV infection who subsequently developed EBV-positive T-cell lymphoma. We found that the patients had evidence of EBV infection in the peripheral blood CD4+ T-cells 19 and 3 months, respectively, before the T-cell lymphoma was diagnosed. The lymphomas were infected with monoclonal EBV and expressed the EBV latency genes EBNA-1, LMP-1, and LMP-2A, a virus latency pattern referred to as latency II. Genetic studies showed that the virus detected in the T-cell lymphoma was indistinguishable from the virus in the peripheral blood CD4+ T-cells. These studies support an important pathogenetic role of T-cell infection with EBV in chronic active EBV infection and in the EBV-positive T-cell lymphoma that followed.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan. kanegane@ms.toyama-mpu.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Kanegane
authors.forename: T
authors.initials: T
authors.lastname: Miyawaki
authors.forename: A
authors.initials: A
authors.lastname: Yachie
authors.forename: T
authors.initials: T
authors.lastname: Oh-Ishi
authors.forename: K
authors.initials: K
authors.lastname: Bhatia
authors.forename: G
authors.initials: G
authors.lastname: Tosato
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D015139:Blotting, Southern; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism / Q000821:virology; D002648:Child; D002675:Child, Preschool; D019309:Epstein-Barr Virus Nuclear Antigens / Q000378:metabolism; D017809:Fatal Outcome; D005260:Female; D006566:Herpesviridae Infections / Q000150:complications*; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D007150:Immunohistochemistry; D016399:Lymphoma, T-Cell / Q000378:metabolism / Q000821:virology*; D008297:Male; D009856:Oncogene Proteins, Viral / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014412:Tumor Virus Infections / Q000150:complications*; D014763:Viral Matrix Proteins / Q000378:metabolism
chemical_list: D015703:Antigens, CD; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; D009856:Oncogene Proteins, Viral; D014763:Viral Matrix Proteins